| __timestamp | Catalent, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 598600000 | 2614539000 |
| Thursday, January 1, 2015 | 615300000 | 3711019000 |
| Friday, January 1, 2016 | 587600000 | 4560733000 |
| Sunday, January 1, 2017 | 654600000 | 5475166000 |
| Monday, January 1, 2018 | 752600000 | 6276700000 |
| Tuesday, January 1, 2019 | 805100000 | 7081200000 |
| Wednesday, January 1, 2020 | 983300000 | 7377200000 |
| Friday, January 1, 2021 | 1352000000 | 13634200000 |
| Saturday, January 1, 2022 | 1640000000 | 10612500000 |
| Sunday, January 1, 2023 | 1060000000 | 11301400000 |
| Monday, January 1, 2024 | 953000000 | 12231500000 |
Igniting the spark of knowledge
In the competitive landscape of biotechnology, Regeneron Pharmaceuticals, Inc. and Catalent, Inc. have showcased distinct trajectories in gross profit performance over the past decade. From 2014 to 2023, Regeneron consistently outperformed Catalent, with its gross profit peaking in 2021 at approximately 13.6 billion, a staggering 900% increase from its 2014 figures. In contrast, Catalent's growth, while steady, was more modest, reaching its zenith in 2022 with a gross profit of around 1.64 billion, marking a 174% rise since 2014.
The year 2021 was particularly noteworthy for Regeneron, as it achieved its highest gross profit, likely driven by its innovative treatments and strategic market positioning. Meanwhile, Catalent's peak in 2022 underscores its resilience and adaptability in a rapidly evolving industry. However, the absence of data for Regeneron in 2024 leaves room for speculation about its future performance.
Key Insights on Gross Profit: Gilead Sciences, Inc. vs Regeneron Pharmaceuticals, Inc.
Gilead Sciences, Inc. and Catalent, Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Regeneron Pharmaceuticals, Inc. vs Incyte Corporation
Regeneron Pharmaceuticals, Inc. or Catalent, Inc.: Who Manages SG&A Costs Better?
Regeneron Pharmaceuticals, Inc. vs Amneal Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Regeneron Pharmaceuticals, Inc. or Amphastar Pharmaceuticals, Inc.
Key Insights on Gross Profit: United Therapeutics Corporation vs Catalent, Inc.
Gross Profit Trends Compared: Bio-Techne Corporation vs Catalent, Inc.
BioMarin Pharmaceutical Inc. and Catalent, Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Catalent, Inc. vs Ascendis Pharma A/S
Gross Profit Comparison: Catalent, Inc. and Jazz Pharmaceuticals plc Trends
Gross Profit Analysis: Comparing Catalent, Inc. and Taro Pharmaceutical Industries Ltd.